Ashley Cordova - 03 Mar 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Financial Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Ashley Cordova
Issuer symbol
NVCR
Transactions as of
03 Mar 2022
Net transactions value
$0
Form type
4
Filing time
11 Mar 2022, 15:55:17 UTC
Previous filing
12 Jan 2022
Next filing
09 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $59,904 +3,840 +6.3% $15.60 64,688 03 Mar 2022 Direct
transaction NVCR Ordinary Shares Options Exercise $13,752 +1,200 +1.9% $11.46 65,888 03 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $59,904 -3,840 -100% $15.60 0 03 Mar 2022 Ordinary Shares 3,840 $15.60 Direct F1
transaction NVCR Options to Buy Ordinary Shares Options Exercise $13,752 -1,200 -13% $11.46 7,736 03 Mar 2022 Ordinary Shares 1,200 $11.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested as of the date hereof.